Abstract
Goals of work
Distress is defined by the National Comprehensive Cancer Network as a multifactorial unpleasant emotional experience of a psychological, social, and/or spiritual nature that may interfere with the ability to cope effectively with cancer. We investigated the prevalence and associated symptoms of distress in newly diagnosed lung cancer patients.
Patients and methods
Between November 2005 and July 2007, 98 newly diagnosed lung cancer patients completed an assessment. The Distress Thermometer (DT) and Edmonton Symptom Assessment Scale (ESAS) were used as screening tools.
Main results
Fifty (51%) patients reported clinically significant distress (≥4) on the DT. Of those, 26 (52%) patients reported high levels of depression, nervousness, or both on ESAS. The remaining 24 (48%) patients had elevated levels of distress but no significant depression or nervousness. A correlation between the DT and the total ESAS score was observed (Pearson correlation = 0.46). The ten items of the ESAS together explained 46% of the variability in DT scores. The depression and nervousness ESAS items were significant predictors of DT score (p < 0.01 for both items). However, once the two psychosocial items, depression and nervousness, were removed from the total ESAS score, leaving only physical symptoms and the sleeplessness item, the predictive power of the model decreased to R² = 0.12.
Conclusions
The prevalence of distress in lung cancer patients is high. The DT appears to discriminate between physical and emotional distress. This easily measured score may determine which patients require further intervention for emotional distress.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Canadian Cancer Society Canadian Cancer Statistics. 2008; Available from: http://www.cancer.ca.
Jemal A et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58(2):71–96. doi:10.3322/CA.2007.0010
World Health Organization International Agency for Research on Cancer (IARC) (2008) World Cancer Report. IARC, Lyon
National Comprehensive Cancer Network. NCCN Non-Small Cell Lung Cancer Clinical Practice Guidelines in Oncology. 2008.
Fallowfield L et al (2001) Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 84(8):1011–1015. doi:10.1054/bjoc.2001.1724
National Comprehensive Cancer Network NCCN Distress Management Clinical Practice Guidelines in Oncology. 2008; Available from: http://www.nccn.org.
Holland J, Bultz B (2007) The NCCN guideline for distress management: a case for making distress the sixth vital sign. J Natl Compr Canc Netw 5(1):3–7
Vitek L, Rosenzweig M, Stollings S (2007) Distress in patients with cancer: definition, assessment, and suggested interventions. Clin J Oncol Nurs 11(3):413–418. doi:10.1188/07.CJON.413-418
Jacobsen P et al (2005) Screening for psychologic distress in ambulatory cancer patients. Cancer 103(7):1494–1502. doi:10.1002/cncr.20940
Bruera E et al (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6–9
Chang V, Hwang S, Feuerman M (2000) Validation of the Edmonton Symptom Assessment Scale. Cancer 88(9):2164–2171. doi:10.1002/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO;2-5
Moro C et al (2006) Edmonton symptom assessment scale: Italian validation in two palliative care settings. Support Care Cancer 14(1):30–37. doi:10.1007/s00520-005-0834-3
Philip J et al (1998) Concurrent validity of the modified Edmonton Symptom Assessment System with the Rotterdam Symptom Checklist and the Brief Pain Inventory. Support Care Cancer 6(6):539–541. doi:10.1007/s005200050212
Zabora J et al (2001) The prevalence of psychological distress by cancer site. Psychooncology 10(1):19–28. doi:10.1002/1099-1611(200101/02)10:1<19::AID-PON501>3.0.CO;2-6
Graves K et al (2007) Distress screening in a multidisciplinary lung cancer clinic: prevalence and predictors of clinically significant distress. Lung Cancer 55(2):215–224. doi:10.1016/j.lungcan.2006.10.001
Néron S et al (2007) Screening for depressive symptoms in patients with unresectable lung cancer. Support Care Cancer 15:1207–1212. doi:10.1007/s00520-007-0225-z
Acknowledgements
This study is supported by The Mona Zavalkoff Fund for Pulmonary Oncology and an unrestricted grant from Sanofi-Aventis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Steinberg, T., Roseman, M., Kasymjanova, G. et al. Prevalence of emotional distress in newly diagnosed lung cancer patients. Support Care Cancer 17, 1493–1497 (2009). https://doi.org/10.1007/s00520-009-0614-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-009-0614-6